Skip to main content
. Author manuscript; available in PMC: 2011 Sep 6.
Published in final edited form as: Int J Pharm. 2006 Dec 3;336(2):233–240. doi: 10.1016/j.ijpharm.2006.11.058

Table 2.

Half-lives (hr) and degradation rate constant (kobs)of SQV prodrugs in intestinal and liver homogenate (1 mg/mL). Studies were conducted at 37 °C. Values reported are mean ± SD (n=3).

Val-Val-SQV Gly-Val-SQV
kobs (hr−1) × 102 t1/2 (hr) kobs (hr−1) × 102 t1/2 (hr)
Intestine 2.3 ± 0.3 29.3 ± 4.2 2.8 ±0.3 24.2 ± 1.1
Liver 26.2 ± 2.7 2.7 ± 0.3 31.2 ± 2.6 2.2 ± 0.2